Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. phrenic nerve
Show results for
Products

Companies

News
Articles

Refine by
Date

  • Older

Phrenic Nerve Articles & Analysis: Older

8 news found

First Patients in the U.S. Enrolled in Biosense Webster Clinical Study To Evaluate VARIPULSE™ Catheter for Atrial Fibrillation

First Patients in the U.S. Enrolled in Biosense Webster Clinical Study To Evaluate VARIPULSE™ Catheter for Atrial Fibrillation

This ablation technique may help spare other tissue types from inadvertent injury to adjacent structures such as the esophagus, pulmonary vein connective tissue and the phrenic nerve.3 “The enrollment of the first patient in the admIRE study marks an important milestone in our journey to bring forward a best-in-class PFA platform to our customers, who have ...

ByJohnson & Johnson Medical Devices Business Services, Inc.


Adagio Medical Announces Successful First-In-Human Cases of Pulsed Field Cryoablation for Treatment of Atrial Fibrillation

Adagio Medical Announces Successful First-In-Human Cases of Pulsed Field Cryoablation for Treatment of Atrial Fibrillation

Clinically, this translates into the prevention of skeletal muscle contraction, phrenic nerve capture, and microbubbles which can be associated with traditional PFA, all while providing effective acute isolation. ...

ByAdagio Medical, Inc.


Avery Biomedical Devices’ Nextgen Diaphragm Pacing Transmitter, Spirit, Earns FDA Approval – Now Available

Avery Biomedical Devices’ Nextgen Diaphragm Pacing Transmitter, Spirit, Earns FDA Approval – Now Available

For those patients who meet the criteria of having functional lungs and diaphragm muscle, as well as an intact phrenic nerve, they can be cleared for the device. It consists of surgically implanted electrodes and receivers with an external transmitter and antennas. ...

ByAvery Biomedical Devices, Inc.


FARAPULSE’s Pivotal Trial to Assess Its Leading Pulsed Field Ablation System for The Treatment of Atrial Fibrillation Receives FDA Conditional Approval

FARAPULSE’s Pivotal Trial to Assess Its Leading Pulsed Field Ablation System for The Treatment of Atrial Fibrillation Receives FDA Conditional Approval

Top line safety results from the Company’s clinical studies showed that the severe complications of PV stenosis and both esophageal and phrenic nerve injury were absent in all patients. The FDA's conditional approval of the IDE allows FARAPULSE to finalize trial arrangements with the participating hospitals prior to patient enrollment, including ...

ByBoston Scientific


First Patients Treated with Galaxy Medical’s CENTAURI Pulsed Electric Field Cardiac Ablation System

First Patients Treated with Galaxy Medical’s CENTAURI Pulsed Electric Field Cardiac Ablation System

In comparison to radio frequency ablation procedures, PEF has the potential to improve the safety of cardiac ablation by reducing the unintentional conductive heating or cooling of extracardiac structures including the esophagus, phrenic nerve and airway. By limiting the therapeutic dose of PEF energy to the heart, full thickness transmural ablations are readily ...

ByGalvanize Therapeutics, Inc.


First COVID-19 Patient in Germany successfully treated with novel Diaphragm Therapy

First COVID-19 Patient in Germany successfully treated with novel Diaphragm Therapy

The Lungpacer® System by Lungpacer Medical Inc., a Canadian medical device company, is a novel technology that stimulates the phrenic nerves during mechanical ventilation and thus strengthens the weakened diaphragm muscle to assist ...

ByLungpacer Medical Inc.


Lungpacer Medical, Inc. Announces FDA Approval of Emergency Use Authorization of the Lungpacer Diaphragm Pacing Therapy System to Help Address COVID-19 Pandemic

Lungpacer Medical, Inc. Announces FDA Approval of Emergency Use Authorization of the Lungpacer Diaphragm Pacing Therapy System to Help Address COVID-19 Pandemic

Lungpacer Medical, Inc., a medical device company developing an intravenous catheter-based phrenic-nerve-pacing system, announced today that the FDA has approved the Emergency Use Authorization for the use of the Lungpacer Diaphragm Pacing Therapy System (DPTS) to assist in weaning patients determined by their healthcare provider to be at high risk of weaning ...

ByLungpacer Medical Inc.


Lungpacer Medical, Inc. Presentations at American Thoracic Society Conference, Scheduled for May 2020, Philadelphia, Pennsylvania

Lungpacer Medical, Inc. Presentations at American Thoracic Society Conference, Scheduled for May 2020, Philadelphia, Pennsylvania

(selected for podium presentation) Temporary Transvenous Phrenic-Nerve-Stimulated Diaphragm Neurostimulation During Mechanical Ventilation Preserves Homogeneity in Non-Injured Lungs, Rohrs, E., et al. ...

ByLungpacer Medical Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT